Millennium Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Millennium Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-52,900	Closed	-$6.57M	–	6101
2025 Q1	$6.57M	Buy	+52,900	New	+$6.9M	﹤0.01%	2604
2024 Q2	–	Sell	-1,700	Closed	-$205K	–	6228
2024 Q1	$205K	Buy	+1,700	New	+$208K	﹤0.01%	5368
2021 Q2	–	Sell	-2,000	Closed	-$329K	–	6789
2021 Q1	$329K	Buy	+2,000	New	+$329K	﹤0.01%	5152
2015 Q1	–	Sell	-4,100	Closed	-$671K	–	3844
2014 Q4	$671K	Buy	+4,100	New	+$681K	﹤0.01%	2794
2014 Q2	–	Sell	-2,600	Closed	-$361K	–	3646
2014 Q1	$361K	Buy	+2,600	New	+$391K	﹤0.01%	2833
2013 Q3	–	Sell	-6,100	Closed	-$419K	–	3443
2013 Q2	$419K	Buy	+6,100	New	+$373K	﹤0.01%	2417

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management's JAZZ Position: Q1 2026 in Review

Millennium Management increased its Jazz Pharmaceuticals (JAZZ) stake by 5% in Q1 2026, buying an estimated $10.5M and bringing the position to 1,262,511 shares worth $239M. The position accounts for 0.1% of the portfolio, ranked #174.

Millennium Management first reported a position in JAZZ in Q2 2013 and has held it in 50 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Millennium Management held 1,262,511 shares of Jazz Pharmaceuticals worth $239M as of Q1 2026.
Millennium Management bought 59,800 Jazz Pharmaceuticals shares in Q1 2026, an estimated $10.5M.
Jazz Pharmaceuticals made up 0.1% of Millennium Management's portfolio in Q1 2026, its #174 holding.
Millennium Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.